Same-day shipping before 2PM PST
Consistency is the cornerstone of effective once-weekly injectable therapy
The awareness campaigns launched by Eli Lilly and Novo Nordisk are therefore aimed at building a broader public understanding of obesity as a treatable medical condition, in anticipation of expanded approvals and the post-patent generic wave, rather than promoting currently approved indications
At 1.0 mg weekly semaglutide, average loss was 1013% of baseline body weight
Though rare, serious risks may include acute pancreatitis, gallbladder disease, and an elevated risk of thyroid tumors
To support whole-body health, we also provide IV therapy, vitamin injections (B12, Lipo, B-complex), hydration support, and hormone-free wellness boosters